Stockscreener 앱 받기
12.87
2.96%
0.37
시간 외 거래:
12.95
0.08
+0.62%
Stoke Therapeutics Inc 주식(STOK)의 최신 뉴스
Analysts Estimate Stoke Therapeutics, Inc. (STOK) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Combining machine learning predictions for Stoke Therapeutics Inc.Free Sector Based Breakout Stock Forecast - Newser
Bullish Candlestick Pattern Forms in Stoke Therapeutics Inc.Sector Based Breakout Stock Forecast Issued - metal.it
Multi asset correlation models including Stoke Therapeutics Inc.Entry Zone Forecast for Momentum Trading - Newser
Price Channel Expanding on Stoke Therapeutics Inc.’s ChartTrade Setups With AI Powered Filters Published - metal.it
What moving averages say about Stoke Therapeutics Inc.Low Risk High Confidence Watchlist Builder - Newser
When is Stoke Therapeutics Inc. stock expected to show significant growthPost Market Picks With Low Risk - jammulinksnews.com
Is Stoke Therapeutics Inc. a growth stock or a value stockGet timely alerts on market movers - jammulinksnews.com
Is it the right time to buy Stoke Therapeutics Inc. stockExpert guidance for superior capital growth - jammulinksnews.com
Stoke Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayPredictable High Return Trades - metal.it
Should I hold or sell Stoke Therapeutics Inc. stock in 2025Earnings Report Alerts For Every Investor - jammulinksnews.com
How strong is Stoke Therapeutics Inc. company’s balance sheetUnlock exclusive investment alerts - jammulinksnews.com
How volatile is Stoke Therapeutics Inc. stock compared to the marketSuperior return velocity - jammulinksnews.com
What are analysts’ price targets for Stoke Therapeutics Inc. in the next 12 monthsDiscover market opportunities others miss - jammulinksnews.com
How does Stoke Therapeutics Inc. generate profit in a changing economyInvest smarter with actionable market insights - jammulinksnews.com
How does Stoke Therapeutics Inc. compare to its industry peersBuild wealth with steady, reliable stocks - jammulinksnews.com
Stoke Therapeutics Inc. Stock Analysis and ForecastFree High-Return Strategy Alerts - PrintWeekIndia
Is Stoke Therapeutics Inc. a good long term investmentSuperior return velocity - Autocar Professional
What analysts say about Stoke Therapeutics Inc. stockExtraordinary market timing - Autocar Professional
Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome - MSN
Stoke Therapeutics Bets Big On Rare Disease Therapies - Finimize
Stoke Therapeutics Soars 17.02% on Market Optimism - AInvest
What drives Stoke Therapeutics Inc. stock priceRobust investment performance - jammulinksnews.com
Why Stoke Therapeutics Inc. stock attracts strong analyst attentionProven Return Strategy Execution - Newser
Published on: 2025-07-22 15:57:09 - jammulinksnews.com
Published on: 2025-07-22 13:02:52 - jammulinksnews.com
Jefferies Financial Group Begins Coverage on Stoke Therapeutics (NASDAQ:STOK) - Defense World
How to Take Advantage of moves in (STOK) - news.stocktradersdaily.com
Is Stoke Therapeutics, Inc.'s (NASDAQ:STOK) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - 富途牛牛
Stoke Therapeutics, Inc.'s (NASDAQ:STOK) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - simplywall.st
Stoke Therapeutics (STOK): A High-Conviction Buy with Disease-Modifying Potential in Dravet Syndrome - AInvest
0.23%
0.40%
자본화:
|
볼륨(24시간):